Skip to content

Control of Trichomoniasis

Control of Trichomoniasis - A Paradigm for STD Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00334555
Enrollment
599
Registered
2006-06-08
Start date
2003-05-31
Completion date
2008-05-31
Last updated
2009-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trichomoniasis

Keywords

trichomoniasis, partner notification

Brief summary

This study is designed to try to find the best method of partner notification and treatment for partners of women with trichomonas

Detailed description

To carry out a randomized trial to compare the effectiveness of three methods of partner notification and treatment for sexual partners of women with vaginal trichomoniasis - patient self-referral of partners (the current practice standard), delivery of curative therapy to partners by patients themselves, or public health style Disease Intervention carried out by a specially trained Disease Intervention Specialists (DIS) locating the partners and delivering the medication in the field. Reinfection rates with trichomonas at three months of follow-up among the index women will be the measure of effectiveness.

Interventions

OTHERdifferent methods of partner notification

comparing patient referral, partner delivered medications and field intervention to treat sex partners

OTHERpartner delivered meds

patient given meds to give to her partner

OTHERfield intervention

health worker finds partners

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Inclusion criteria {for Women}: Age {\> 15 years} Culture or wet prep proven T. vaginalis infection Willingness to provide informed consent and take part in study procedures \-

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frame
recurrence of trichomonas in the index patient6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026